Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > Tieks13, TFSA accounts

<< Previous

Bullboard Posts

Next >>

Comment by coolshiverson Jan 09, 2021 3:35pm

119 Views

Post# 32261762

RE:RE:RE:RE:RE:RE:RE:RE:RE:Tieks13, TFSA accounts

Yes. It is an in kind transfer at the last business day close. Or end of day close. You would dispose of the asset in your investment account. That means. If you bought at 10 and moved it at 45. You would pay capital gains tax in your investment account on 35 cents. Or if you transferred at 5 and bought at 10 you would have a capital loss. But if you don't have anymore money. But you own shares. This is a good strategy if you have room in your TSFA.

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide